In anticipation of World Menopause Day, the International Menopause Society (IMS) has released groundbreaking research shedding light on female-specific cardiovascular disease (CVD) risk factors. The study, titled ‘Reproductive Milestones Across the Lifespan and Cardiovascular Disease Risk in Women,’ highlights the numerous milestones in a woman’s life associated with increased CVD risks, including menstruation, menopause, and adverse pregnancy outcomes.

The research underscores the urgent need to recognise and address these sex-specific risk factors. Despite advancements in diagnosis and treatment, CVD remains the leading global cause of death in women, responsible for 35% of female deaths annually, surpassing the mortality rate of breast cancer by more than 13 times.

The study also emphasises the importance of early detection for breast cancer, urging individuals above the age of 40 to undergo annual screenings. Age, family history, gene mutations, lack of physical activity, and being overweight are identified as risk factors. Regular breast examinations and a healthy lifestyle are key preventive measures.

Also Read: Hormone Therapy Proves Safe and Beneficial, Even for High-Risk Patients, Research Suggests

Additionally, researchers have identified nearly a dozen genes contributing to calcium buildup in coronary arteries, a precursor to coronary artery disease. This breakthrough could pave the way for the development of drugs or dietary supplements to prevent or delay the progression of this disease, potentially revolutionising early interventions.

Furthermore, an increasing number of women in their 40s are experiencing early menopause, attributed to genetic, lifestyle, and environmental factors. Support and proactive adjustments to maintain good health are recommended for women facing early menopause, with consultations with healthcare providers crucial for managing specific symptoms and exploring treatment options.

This research serves as a clarion call for increased awareness, proactive screenings, and tailored interventions to empower women and healthcare providers in the prevention and management of female-specific cardiovascular risks. Stay tuned for further updates as the medical community continues to delve into these critical findings.